Clinical review

Recent advances in intensive care

Stephen Stott, consultant in anaesthesia and intensive care. 

Grampian University Hospitals Trust, Aberdeen AB25 2ZN

s.a.stott{at}abdn.ac.uk

Intensive care medicine has had its fair share of publicity over the past few years but mainly for reasons of shortness of resources rather than major medical advances. Despite this and the difficulty of doing research in this heterogeneous and relatively small population group, there have been several significant advances in the past few years. This article discusses some of these as well as the advances in training that have recently taken place.

	Methods

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

I wrote this review using information from articles found through the Medline database on topics that I selected. Because of space restrictions it cannot be a comprehensive review of all recent advances. Key words used in the database search included nutrition, intensive care, acute respiratory distress syndrome, and tracheostomy

	Acute respiratory distress syndrome

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

It is now over 30 years since the acute respiratory distress syndrome was described, and it is now known to be the extreme end of a continuum of lung injury. A consensus definition in 1994 (box)¹ has allowed accurate classification of lung injury and better standardisation in clinical research. The early reported mortality of 60% now seems to be falling, with recent reports of 30-40% from both the United States² and the United Kingdom,³ but the reasons for this improvement are still unclear. As these patients usually do not die of respiratory failure but of the development of multiple organ failure, no single treatment that may attenuate the lung injury is likely to be responsible for the increased survival. The improvement in general care, attention to areas such as infection and nutrition, and a better understanding of the pathophysiology of the disease process have contributed substantially to the improved survival. Several areas, however, deserve mention.

Mechanical ventilation
Although ventilation is the mainstay of support for acute respiratory failure, it is now recognised that this can itself lead to damage in both normal and diseased lungs. The acute respiratory distress syndrome is not a homogenous disease, having areas of normal and diseased lung adjacent to each other. Diseased lung requires greater distending pressures and volumes to open and recruit involved alveoli. This can lead to pressure damage (barotrauma) or volume damage (volutrauma) in adjacent, normal, compliant lung units. This, and the shearing forces exerted because of repeated opening and closing of stiff alveoli, results in inflammation that can worsen and prolong the lung injury. Recognition of this ventilator induced lung injury has led to the investigation of so-called protective strategies of ventilation. These strategies lower distending pressures and volumes and split alveoli open with higher levels of positive end expiratory pressure. Differing results have been reported for such strategies: Amato and coworkers reported an increase in oxygenation and a decrease in 28 day mortality⁴; other workers have not repeated this result,⁵ but a recent trial by the National Heart, Lung, and Blood Institute (US National Institutes of Health) into protective ventilator strategy has been stopped early after enrolment of 800 of the proposed 1000 patients because of a 25% reduction in mortality in those assigned to the smaller tidal volume group.⁶

Inhaled therapy
The pathophysiology of the acute respiratory distress syndrome includes pulmonary vasoconstriction, leading to ventilation and perfusion mismatching and systemic hypoxia. Administering vasodilating agents by the inhalational route can avoid systemic effects and can lead to improvements in arterial oxygenation as ventilated alveoli become better perfused. Attention has focused on agents that are rapidly inactivated, thus minimising systemic effects. Nitric oxide, a potent vasodilator, has now been well studied in the treatment of refractory hypoxia in acute lung injury. It is produced as medical grade gas in cylinders and is relatively easily delivered into the inspiratory limb of the breathing circuit. It does, however, need specialised monitoring equipment as products of its combination with oxygen include nitrogen dioxide. It is avidly bound to haemoglobin, and so its effects are short lasting and systemic hypotension is rare. It has been shown to improve oxygenation in so-called responders with acute lung injury but so far has not been shown to increase survival. ^{7 8} UK guidelines have been produced for its use.⁹ Prostacyclin, another powerful pulmonary vasodilator, is easier to administer. Used with an infusion pump connected to a continuous nebuliser in the inspiratory limb of the circuit, it has also been shown to improve oxygenation.¹⁰

Prone position
Traditionally, patients are nursed supine in intensive care. Although it has been known since 1976 that an alteration in body position to prone will improve oxygenation in patients with the acute respiratory distress syndrome,¹¹ this measure has only recently been applied clinically. After Gattinoni and colleagues showed the effects that changing the body position have on ventilation distribution in these patients¹² numerous studies have now shown an improvement in oxygenation when patients are turned to prone position. ^{13 14} This can be achieved with minimal complications despite the presence of multiple indwelling vascular lines. The optimum time before the patient is turned again to supine is unresolved, with some advocating regular timed intervals and others leaving patients prone until oxygenation deteriorates. The exact mechanism resulting in the improvement in oxygenation is not yet understood, but caudal movement of the diaphragm, a more uniform gradient of pleural pressure, and recruitment of collapsed alveoli will all lead to a decrease in shunt fraction and all play a part.

View larger version (158K): [in this window] [in a new window]   Chest radiograph showing radiological features consistent with acute respiratory distress syndrome

	Nutrition

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

The concept that altering diet can change outcome is not new in medicine and has now been applied to critically ill people. Accurate nutritional targets are important as both overfeeding and underfeeding have led to increased morbidity. Interest has now shifted to the ingredients of diet. Vitamins A, C, and E, as well as the amino acids arginine¹⁸ and glutamine,¹⁹ have all been shown to boost immune function, as have ribonucleotides and a change from omega 6 to omega 3 free fatty acids.²⁰ These fatty acids function as important regulators of numerous cellular functions and affect many cell signalling pathways. Membrane fluidity, ion channel flow, and cell surface receptor function (as well as the generation of prostaglandins, leukotrienes, cytokines, and expression of inflammatory gene products) are some of the processes involved. The switch from omega 6 to omega 3 fatty acids is associated with a reduction in the production of proinflammatory mediators. Early studies comparing different formulations did not match energy or protein intake, but this shortcoming has now been addressed. Recent studies have concentrated on intensive care patients and shown a reduction in infective complications, days on a ventilator, and length of stay, but so far mortality has not improved. ^{21 22} The best formulation and which group of patients will benefit most have yet to be elucidated. In an attempt to do this, Gadek et al conducted a prospective randomised, double blind, multicentre study using eicosapentaenoic acid (an omega 3 polyunsaturated fatty acid) and  linolenic acid (an omega 6 polyunsaturated fatty acid) plus antioxidants in patients with the acute respiratory distress syndrome. They showed faster resolution of lung inflammation, as assessed by inflammatory cells in bronchial-alveolar lavage fluid, and faster improvement in the ratio of fractional inspired oxygen to arterial oxygen tension in those receiving the study feed²³; these patients also had shorter ventilator requirements, shorter stays in intensive care, and fewer new organ failures.

Patients unable to tolerate enteral feed can be fed parenterally. Glutamine, which in health is a non-essential amino acid, becomes severely depleted in critically ill patients but has not been added to total parenteral nutrition solutions because of stability problems. Griffiths and colleagues overcame this, showing that total parenteral nutrition supplemented with glutamine resulted in a reduction in mortality at six months.²⁴

	Equipment and monitoring

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

Evidence for the benefit of the plethora of equipment in intensive care units is sparse, but some equipment has become synonymous with these units. The pulmonary artery flotation catheter has been the bedrock of invasive cardiovascular monitoring since its introduction in 1976, but doubt has been raised about its value after a paper arising from the SUPPORT trial in the United States. ^{25 26} This showed an increase in 30 day mortality (odds ratio 1.24, confidence interval 1.03 to 1.49) associated with its use. A propensity scoring system was used to compare patients managed with and without a catheter. The furore that this has caused still reverberates in the world of intensive care, with some calling for a complete moratorium on its use.²⁷ The European Society of Intensive Care Medicine has since produced guidelines for its use,²⁸ and trials are under way to try to resolve this issue.²⁹ The important variable seems unlikely to be the catheter itself; it is more likely to be the indication for its use and the actions taken on the data produced by it.

In the next few years non-invasive or low-invasive methods of assessing the cardiovascular system are likely to find their niche, ^{30 31} although they will have to show cost effectiveness in a field that already consumes a large slice of health resources. As extensive investigations into oxygen supply and demand relations have queried the relation between cardiac output and tissue oxygenation,³² it remains to be seen if global cardiac output measurement and manipulation is the correct road to go down.

	Tracheostomy

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

Tracheostomy is used frequently in critically ill patientsto facilitate weaning from mechanical ventilation, for patients' comfort, to ease tracheobronchial toilet, or for airway protection. Formal surgical tracheostomy requires transporting the patient to the operating theatre and the support of the theatre and anaesthetic team and is associated with a significant complication rate.³³ Bedside percutaneous dilatational tracheostomy was first described in 1985,³⁴ and several modifications have been reported since.³⁵ It has now become an established part of intensive care and is a cost effective procedure.³⁶ The trachea is located with a needle between the second and third rings and a guidewire inserted. Serial dilatation over the wire then allows the tracheostomy tube to be inserted. Chances of misplacement are reduced if bronchoscopic guidance is concurrently used,³⁷ and follow up series show that both early and late morbidity is lower than with open surgery.³⁸

View larger version (41K): [in this window] [in a new window]   Location of the tracheal lumen with guidewire for percutaneous tracheostomy

	Intensive care training

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

In 1993 the Royal Colleges of Anaesthetists, Physicians, and Surgeons established the Intercollegiate Committee on Intensive Therapy to set up training programmes for trainees who wished either to be a consultant or to have a significant input in intensive care medicine. It put forward proposals on exposure for medical students and requirements for doctors already registered. Implementation of these recommendations has become the responsibility of the Intercollegiate Board for Training in Intensive Care Medicine. Trainees have to undertake at least 3 months' intensive care medicine as a senior house officer, ideally in a unit that is recognised by the board. They then undergo intermediate training in intensive care medicine, consisting of six months in intensive care and six months in a complementary specialtyfor example, anaesthesia for a physician or acute general medicine for an anaesthetist. Surgeons need exposure to both anaesthesia and medicine.

For those who will have a near full time commitment to intensive care medicine or be unit directors there needs to be a further year's training (advanced training) to cover the organisational aspects of intensive care and exposure to specialised units. The board has submitted an application for specialty status to the Specialist Training Authority for recognition as a schedule 2 specialty. A diploma in intensive care medicine had its first sitting in July 1998. Over 100 units have now been granted interim recognition for training, and a body of advisers in intensive care medicine has been appointed, including regional advisers, to ensure continuing passage of information and maintenance of standards. Further details regarding training can be downloaded from the board's web page (www.ncl.ac.uk/nsa/ibtic ).

	Footnotes

   Funding: None.

Competing interests: None declared.

	References

Top Methods Acute respiratory distress... Nutrition Equipment and monitoring Tracheostomy Intensive care training References

1.	Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial co-ordination. Am J Respir Clin Care Med 1994; 194: 818-824.
2.	Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273: 306-309[Abstract].
3.	Abel SJC, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998; 53: 292-294[Abstract/Free Full Text].
4.	Amato MBP, Barbas CSV, Medeiros DM, Magaldi RB, Schettino GP. Effect of a protective-ventilation strategy on mortality in acute respiratory distress syndrome. N Engl J Med 1998; 338: 347-354[Abstract/Free Full Text].
5.	Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk of developing the acute respiratory distress syndrome. N Engl J Med 1998; 338: 355-361[Abstract/Free Full Text].
6.	www.hedwig.mgh.harvard.edu/ardsnet (accessed 14 December 1999).
7.	Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, et al. Effects of inhaled nitric oxide inpatients with acute respiratory distress syndrome: results of a randomised phase II trial. Crit Care Med 1998; 26: 15-24[CrossRef][Medline].
8.	Lundin S, Mang H, Smitheies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Intensive Care Med 1999; 25: 911-919[CrossRef][Medline].
9.	Cuthbertson BH, Dellinger P, Dyar OJ, Evans TE, Higenbottam T, Latimer R, et al. The UK guidelines for the use of inhaled nitric oxide therapy in adult ICU's. Intensive Care Med 1997; 23: 1212-1218[CrossRef][Medline].
10.	Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller M, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154: 1671-1677[Abstract].
11.	Piehl MA, Brown RS. Use of extreme position change in acute respiratory failure. Crit Care Med 1976; 4: 13-14[Medline].
12.	Gattinoni L, Pelosi P, Vitale G, Presenti A, D'Andrea L, Macheroni D. Body changes redistribute lung computed tomographic density in patients with acute respiratory failure. Anaesthesiology 1991; 74: 15-23[Medline].
13.	Jolliet P, Bulpa P, Chevrolet JC. Effects of prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Med 1998; 12: 1977-1985.
14.	Flaaten H, Aardel S, Hevroy O. Improved oxygenation using the prone position in patients with ARDS. Acta Anaesthiol Scand 1998; 3: 329-334.
15.	Papazian L, Bregeon F, Gaillet F, Thirion X, Gainnier M, Gregoire R, et al. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157: 580-585[Abstract/Free Full Text].
16.	Germann P, Ziesche R, Leitner C, Roeder G, Urak G, Zimpfer M, et al. Additive effects of nitric oxide inhalation on the oxygenation benefit of the prone position in the acute respiratory distress syndrome. Anaesthesiology 1998; 89: 1401-1406[CrossRef][Medline].
17.	Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159-165[Abstract/Free Full Text].
18.	Brittenden J, Watmough D, Eremin O. L-arginine stimulates host defences in patients with breast cancer. Surgery 1994; 115: 205-212[Medline].
19.	O'Riordain MG, Fearon KC, Ross JA, Rogers P, Falconer JS, Bartolo DC, et al. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994; 220: 212-221[Medline].
20.	Blok WL, Katn MB, ven der Meer JW. Modulation of inflammation and cytokine production by dietary (n=3) fatty acids. J Nutr 1996; 126: 1515-1533.
21.	Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group. Crit Care Med 1998; 26: 1164-1172[CrossRef][Medline].
22.	Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systemic review on clinical outcome. Crit Care Med (in press).
23.	Gadek JE, DeMichele SJ, Karstad MD, Pacht ER, Donahoe M, Albertson TE, et al. Effect of enteral feeding with eicosapentaenoic acid, ( linolenic acid and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999; 27: 1409-1420[CrossRef][Medline].
24.	Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13: 295-302[Medline].
25.	SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill patients. The study to understand prognosis and preferences for outcomes and risks of treatment (SUPPORT). JAMA 1995; 274: 1591-1598[Abstract].
26.	Connors Jr AF, Speroff T, Dawson NV, Thomas C, Harrell Jr FE, Wagner D, et al. The effectiveness of right heart catheterisation in the initial care of critically ill patients. JAMA 1996; 276: 889-897[Abstract].
27.	Dalen JE, Bone RC. Is it time to pull the pulmonary catheter? JAMA 1996; 276: 916-918[CrossRef][Medline].
28.	European Society of Intensive Care Medicine Expert panel. The use of the pulmonary artery catheter. Intensive Care Med 1991; 17: I-VIII[CrossRef][Medline].
29.	Sandham JD, Hull RD, Brant RF. The pulmonary artery takes a great fall. Crit Care Med 1998; 26: 1288-1289[CrossRef][Medline].
30.	Cariou A, Monchi M, Joly LM, Bellenfant F, Claessens YE, Thebert D, et al. Non-invasive cardiac output monitoring by aortic blood flow determination: evaluation of the Sometec Dynemo-3000 system. Crit Care Med 1998; 26: 2066-2072[CrossRef][Medline].
31.	Poelaert J, Schmidt C, Van Aken H, Hinder F, Mollhoff T, Loick HM. A comparison of transoesophageal echocardiographic Doppler across the aortic valve and the thermodilution technique for estimating the cardiac output. Anaesthesia 1999; 54: 128-136[CrossRef][Medline].
32.	Pinsky MR. Beyond global oxygen supply-demand relations: in search of measures of dysoxia. Intensive Care Med 1994; 20: 1-3[CrossRef][Medline].
33.	Heffner JE, Miller KS, Sahn SA. Tracheostomy in the intensive care unit. II. Complications. Chest 1986; 14: 742.
34.	Ciaglia P, Firsching R, Syniec C. Elective percutaneous dilatational tracheostomy: a new simple bedside procedurepreliminary report. Chest 1985; 87: 715[Abstract/Free Full Text].
35.	Schachner A, Ovil Y, Sidi J, Rogev M, Heilbronn Y, Levy MJ. Percutaneous tracheostomya new method. Crit Care Med 1989; 17: 1052-1056[Medline].
36.	Cobean R, Beals M, Moss C, Bredenberg CE. Percutaneous dilatational tracheostomy. A safe, cost-effective bedside procedure. Arch Surg 1996; 131: 265-269[Abstract].
37.	Winkler W-B, Karnik R, Seelman O, Havlicek J, Slany J. Bedside percutaneous dilatational tracheostomy with endoscopic guidance: experience with 71 ICU patients. Intensive Care Med 1994; 20: 476-479[CrossRef][Medline].
38.	Hill BB, Zweng TN, Maley RH, Charash WE, Toursarkissian B, Kearney P. Percutaneous dilatational tracheostomy: report of 356 cases. J Trauma 1996; 41: 238-243[Medline].